Crispr Therapeutics AG(CRSP)
$42.24-0.38 (-0.89%)
CRSP
Crispr Therapeutics AG financials statements
$42.24
At close:-0.38 (-0.89%)
Want to see CRSP full AI Analyst Report?
Crispr Therapeutics AG (CRSP) Income Statement
11,100 Followers
Crispr Therapeutics AG Income Statement
Last quarter (Q3 2026), Crispr Therapeutics AG's total revenue was $12.67M, an increase of 1325.08% from the same quarter last year. In Q3, Crispr Therapeutics AG's net income was $-111.44M. See Crispr Therapeutics AG’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 3.51M | $ 35.00M | $ 370.00M | $ 436.00K | $ 913.08M | |
| $ -229.45M | $ -75.25M | $ 239.75M | $ -109.81M | $ 811.90M | |
| $ 338.87M | $ 391.32M | $ 462.29M | $ 563.35M | $ 438.38M | |
| Depreciation and Amortization | $ 19.48M | $ 19.26M | $ 19.84M | $ 24.17M | $ 17.95M |
| $ -558.49M | $ -343.41M | $ -130.88M | $ -626.33M | $ 397.48M | |
| $ -568.32M | $ -466.57M | $ -222.54M | $ -673.16M | $ 373.53M | |
| $ -9.65M | $ 103.90M | $ 71.82M | $ 22.66M | $ 6.00M | |
| $ -577.97M | $ -362.67M | $ -150.72M | $ -650.50M | $ 379.53M | |
| $ -581.60M | $ -366.25M | $ -153.61M | $ -650.17M | $ 377.66M | |
| Per Share Metrics | |||||
| Basic EPS | $ -6.47 | $ -4.34 | $ -1.94 | $ -8.36 | $ 4.97 |
| Diluted EPS | $ -6.47 | $ -4.34 | $ -1.94 | $ -8.36 | $ 4.70 |
| Weighted Average Shares Outstanding | 89.93M | 84.36M | 79.22M | 77.75M | 75.95M |
| Weighted Average Shares Outstanding (Diluted) | 89.93M | 84.36M | 79.22M | 77.75M | 80.39M |
Currency in USD
